{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:35:00Z","timestamp":1790681700517,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Sten A Olssons Foundation for Research and Culture"},{"DOI":"10.13039\/100007436","name":"Familjen Erling-Perssons Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007464","name":"Torsten S\u00f6derbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BILTEMA Foundation"},{"name":"lngaBritt and Arne Lundbergs Foundation"},{"DOI":"10.13039\/100009604","name":"Stichting af Jochnick Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009604","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jane and Dan Olssons Research Foundation,"},{"name":"Nexttobe"},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012538","name":"Swedish Cancer Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012538","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Thematic Cardiovascular Research Center and Stockholm County Council"},{"name":"the Swedish Heart-Lung Foundation"},{"name":"VINNOVA-BIO-X and Medivir AB"},{"name":"Cure cancer \/Bota Cancer"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4012-7","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T09:30:58Z","timestamp":1517909458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?"],"prefix":"10.1186","volume":"18","author":[{"given":"Suhas","family":"Vasaikar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgos","family":"Tsipras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Land\u00e1zuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Wilhelmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Scicluna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan L.","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul-Aleem","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belghis","family":"Davoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingmei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharan","family":"Ananthaseshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klas","family":"Str\u00e5\u00e5t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Stragliotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsar","family":"Rahbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kum Thong","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Tegner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5329-1815","authenticated-orcid":false,"given":"Koon-Chu","family":"Yaiw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"S\u00f6derberg-Naucler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,6]]},"reference":[{"issue":"6","key":"4012_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/jnen\/64.6.479","volume":"64","author":"H Ohgaki","year":"2005","unstructured":"Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005;64(6):479\u201389.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"4012_CR2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1056\/NEJMra0708126","volume":"359","author":"PY Wen","year":"2008","unstructured":"Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359(5):492\u2013507.","journal-title":"N Engl J Med"},{"issue":"1","key":"4012_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/01.coc.0000045852.88461.80","volume":"27","author":"ML Gruber","year":"2004","unstructured":"Gruber ML, Buster WP. Temozolomide in combination with irinotecan for treatment of recurrent malignant glioma. Am J Clin Oncol. 2004;27(1):33\u20138.","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"4012_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bcp.2012.03.020","volume":"84","author":"MQ Mazzuca","year":"2012","unstructured":"Mazzuca MQ, Khalil RA. Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease. Biochem Pharmacol. 2012;84(2):147\u201362.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"4012_CR5","first-page":"305","volume":"18","author":"E Eltze","year":"2007","unstructured":"Eltze E, Bertolin M, Korsching E, Wulfing P, Maggino T, Lelle R. Expression and prognostic relevance of endothelin-B receptor in vulvar cancer. Oncol Rep. 2007;18(2):305\u201311.","journal-title":"Oncol Rep"},{"issue":"5","key":"4012_CR6","doi-asserted-by":"publisher","first-page":"E693","DOI":"10.1002\/ijc.27419","volume":"131","author":"D Wuttig","year":"2012","unstructured":"Wuttig D, Zastrow S, Fussel S, Toma MI, Meinhardt M, Kalman K, Junker K, Sanjmyatav J, Boll K, Hackermuller J, et al. CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases. Int J Cancer. 2012;131(5):E693\u2013704.","journal-title":"Int J Cancer"},{"issue":"4","key":"4012_CR7","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/bjc.2013.784","volume":"110","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Sho M, Takayama T, Wakatsuki K, Matsumoto S, Migita K, Ito M, Hamada K, Nakajima Y. Endothelin B receptor expression correlates with tumour angiogenesis and prognosis in oesophageal squamous cell carcinoma. Br J Cancer. 2014;110(4):1027\u201333.","journal-title":"Br J Cancer"},{"issue":"2","key":"4012_CR8","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1476-5381.2011.01217.x","volume":"163","author":"A Bagnato","year":"2011","unstructured":"Bagnato A, Loizidou M, Pflug BR, Curwen J, Growcott J. Role of the endothelin axis and its antagonists in the treatment of cancer. Brit J Pharmacol. 2011;163(2):220\u201333.","journal-title":"Brit J Pharmacol"},{"issue":"1","key":"4012_CR9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3892\/mmr.2013.1746","volume":"9","author":"X Wan","year":"2014","unstructured":"Wan X, Zhang LB, Jiang B. Role of endothelin B receptor in oligodendroglioma proliferation and survival: in vitro and in vivo evidence. Mol Med Rep. 2014;9(1):229\u201334.","journal-title":"Mol Med Rep"},{"issue":"5","key":"4012_CR10","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1158\/1078-0432.CCR-10-2340","volume":"17","author":"J Asundi","year":"2011","unstructured":"Asundi J, Reed C, Arca J, McCutcheon K, Ferrando R, Clark S, Luis E, Tien J, Firestein R, Polakis P. An antibody-drug conjugate targeting the endothelin B receptor for the treatment of melanoma. Clin Cancer Res. 2011;17(5):965\u201375.","journal-title":"Clin Cancer Res"},{"issue":"20","key":"4012_CR11","doi-asserted-by":"publisher","first-page":"4630","DOI":"10.1158\/1078-0432.CCR-14-3195","volume":"21","author":"SJ Kim","year":"2015","unstructured":"Kim SJ, Lee HJ, Kim MS, Choi HJ, He J, Wu Q, Aldape K, Weinberg JS, Yung WK, Conrad CA, et al. Macitentan, a dual Endothelin receptor antagonist, in combination with Temozolomide leads to Glioblastoma regression and long-term survival in mice. Clin Cancer Res. 2015;21(20):4630\u201341.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"4012_CR12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3109\/00207454.2011.602808","volume":"121","author":"C Shen","year":"2011","unstructured":"Shen C, Yang L, Yuan X. Endothelin B receptor expression in human astrocytoma: association with clinicopathological variables and survival outcomes. Int J Neurosci. 2011;121(11):626\u201331.","journal-title":"Int J Neurosci"},{"issue":"3","key":"4012_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s11060-014-1582-3","volume":"120","author":"T Ratneswaren","year":"2014","unstructured":"Ratneswaren T, Jack RM, Tataru D, Davies EA. The survival of patients with high grade glioma from different ethnic groups in south East England. J Neuro-Oncol. 2014;120(3):531\u20136.","journal-title":"J Neuro-Oncol"},{"issue":"10","key":"4012_CR14","first-page":"3949","volume":"61","author":"P Chen","year":"2001","unstructured":"Chen P, Aldape K, Wiencke JK, Kelsey KT, Miike R, Davis RL, Liu J, Kesler-Diaz A, Takahashi M, Wrensch M. Ethnicity delineates different genetic pathways in malignant glioma. Cancer Res. 2001;61(10):3949\u201354.","journal-title":"Cancer Res"},{"issue":"1","key":"4012_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jcv.2012.12.018","volume":"57","author":"A Rahbar","year":"2013","unstructured":"Rahbar A, Orrego A, Peredo I, Dzabic M, Wolmer-Solberg N, Straat K, Stragliotto G, Soderberg-Naucler C. Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival. J Clin Virol. 2013;57(1):36\u201342.","journal-title":"J Clin Virol"},{"issue":"7","key":"4012_CR16","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"key":"4012_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2202-14-3","volume":"14","author":"SV Vasaikar","year":"2013","unstructured":"Vasaikar SV, Padhi AK, Jayaram B, Gomes J. NeuroDNet - an open source platform for constructing and analyzing neurodegenerative disease networks. BMC Neurosci. 2013;14:3.","journal-title":"BMC Neurosci"},{"issue":"3","key":"4012_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/bioinformatics\/btq675","volume":"27","author":"ME Smoot","year":"2011","unstructured":"Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27(3):431\u20132.","journal-title":"Bioinformatics"},{"issue":"43","key":"4012_CR19","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. P Natl Acad Sci USA. 2005;102(43):15545\u201350.","journal-title":"P Natl Acad Sci USA"},{"issue":"11","key":"4012_CR20","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/labinvest.3780178","volume":"80","author":"G Egidy","year":"2000","unstructured":"Egidy G, Eberl LP, Valdenaire O, Irmler M, Majdi R, Diserens AC, Fontana A, Janzer RC, Pinet F, Juillerat-Jeanneret L. The endothelin system in human glioblastoma. Lab Investig. 2000;80(11):1681\u20139.","journal-title":"Lab Investig"},{"issue":"1","key":"4012_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98\u2013110.","journal-title":"Cancer Cell"},{"issue":"3","key":"4012_CR22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ccell.2015.02.007","volume":"27","author":"C Rubio-Perez","year":"2015","unstructured":"Rubio-Perez C, Tamborero D, Schroeder MP, Antolin AA, Deu-Pons J, Perez-Llamas C, Mestres J, Gonzalez-Perez A, Lopez-Bigas N. In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities. Cancer Cell. 2015;27(3):382\u201396.","journal-title":"Cancer Cell"},{"issue":"8","key":"4012_CR23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1139\/Y08-058","volume":"86","author":"A Bagnato","year":"2008","unstructured":"Bagnato A, Spinella F, Rosano L. The endothelin axis in cancer: the promise and the challenges of molecularly targeted therapy. Can J Physiol Pharm. 2008;86(8):473\u201384.","journal-title":"Can J Physiol Pharm"},{"issue":"5","key":"4012_CR24","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.eururo.2008.10.003","volume":"56","author":"E Eltze","year":"2009","unstructured":"Eltze E, Wild PJ, Wulfing C, Zwarthoff EC, Burger M, Stoehr R, Korsching E, Hartmann A. Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters. Eur Urol. 2009;56(5):837\u201345.","journal-title":"Eur Urol"},{"issue":"5","key":"4012_CR25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s004280000362","volume":"438","author":"A Demunter","year":"2001","unstructured":"Demunter A, De Wolf-Peeters C, Degreef H, Stas M, van den Oord JJ. Expression of the endothelin-B receptor in pigment cell lesions of the skin - evidence for its role as tumor progression marker in malignant melanoma. Virchows Arch. 2001;438(5):485\u201391.","journal-title":"Virchows Arch"},{"issue":"2","key":"4012_CR26","first-page":"457","volume":"23","author":"S Blouquit-Laye","year":"2010","unstructured":"Blouquit-Laye S, Regnier A, Beauchet A, Zimmermann U, Devillier P, Chinet T. Expression of endothelin receptor subtypes in bronchial tumors. Oncol Rep. 2010;23(2):457\u201363.","journal-title":"Oncol Rep"},{"issue":"2","key":"4012_CR27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1158\/1078-0432.CCR-10-1126","volume":"17","author":"M de Tayrac","year":"2011","unstructured":"de Tayrac M, Aubry M, Saikali S, Etcheverry A, Surbled C, Guenot F, Galibert MD, Hamlat A, Lesimple T, Quillien V, et al. A 4-gene signature associated with clinical outcome in high-grade gliomas. Clin Cancer Res. 2011;17(2):317\u201327.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4012_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1527-3466.2006.00063.x","volume":"24","author":"H Vatter","year":"2006","unstructured":"Vatter H, Seifert V. Ambrisentan, a non-peptide endothelin receptor antagonist. Cardiovasc Drug Rev. 2006;24(1):63\u201376.","journal-title":"Cardiovasc Drug Rev"},{"issue":"1","key":"4012_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11060-015-2017-5","volume":"127","author":"S Nakashima","year":"2016","unstructured":"Nakashima S, Sugita Y, Miyoshi H, Arakawa F, Muta H, Ishibashi Y, Niino D, Ohshima K, Terasaki M, Nakamura Y, et al. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas. J Neuro-Oncol. 2016;127(1):23\u201332.","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"4012_CR30","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/oxfordjournals.epirev.a036200","volume":"17","author":"PD Inskip","year":"1995","unstructured":"Inskip PD, Linet MS, Heineman EF. Etiology of brain tumors in adults. Epidemiol Rev. 1995;17(2):382\u2013414.","journal-title":"Epidemiol Rev"},{"issue":"6","key":"4012_CR31","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1227\/NEU.0b013e3181f743f5","volume":"67","author":"P Jha","year":"2010","unstructured":"Jha P, Suri V, Jain A, Sharma MC, Pathak P, Srivastava A, Suri A, Gupta D, Chosdol K, Chattopadhyay P, et al. O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment. Neurosurgery. 2010;67(6):1681\u201391.","journal-title":"Neurosurgery"},{"issue":"2","key":"4012_CR32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/glia.10173","volume":"41","author":"SD Rogers","year":"2003","unstructured":"Rogers SD, Peters CM, Pomonis JD, Hagiwara H, Ghilardi JR, Mantyh PW. Endothelin B receptors are expressed by astrocytes and regulate astrocyte hypertrophy in the normal and injured CNS. Glia. 2003;41(2):180\u201390.","journal-title":"Glia"},{"issue":"2-3","key":"4012_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0165-0173(99)00003-X","volume":"29","author":"JB Cavanagh","year":"1999","unstructured":"Cavanagh JB. Corpora-amylacea and the family of polyglucosan diseases. Brain Res Brain Res Rev. 1999;29(2-3):265\u201395.","journal-title":"Brain Res Brain Res Rev"},{"key":"4012_CR34","doi-asserted-by":"crossref","unstructured":"Libard S, Popova SN, Amini RM, Karja V, Pietilainen T, Hamalainen KM, Sundstrom C, Hesselager G, Bergqvist M, Ekman S et al: Human Cytomegalovirus Tegument Protein pp65 Is Detected in All Intra- and Extra-Axial Brain Tumours Independent of the Tumour Type or Grade. PLoS One. 2014; 9(9):e108861(1-14).","DOI":"10.1371\/journal.pone.0108861"},{"key":"4012_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.","journal-title":"BMC Bioinformatics"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4012-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T06:29:19Z","timestamp":1570688959000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4012-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,6]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4012"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4012-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,6]]},"assertion":[{"value":"30 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The use of patient materials was approved by the Ethics Committee at the Karolinska Institutet and by the Medical Ethics Committee, University of Malaya Medical Center, Malaysia, and conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A patent application for use of ETBR inhibitors in prevention and treatment of HCMV infection and CMV-related pathologies such as cardiovascular diseases and cancer has been filed (to CSN and KCY).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"154"}}